Found: 7
Select item for more details and to access through your institution.
Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumors.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 340, doi. 10.1007/s10637-013-0048-3
- By:
- Publication type:
- Article
Accumulation of hypoxia-inducible factor-1α is limited by transcription-dependent depletion.
- Published in:
- Oncogene, 2005, v. 24, n. 30, p. 4829, doi. 10.1038/sj.onc.1208636
- By:
- Publication type:
- Article
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets.
- Published in:
- Clinical Epigenetics, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13148-020-00876-8
- By:
- Publication type:
- Article
Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 4, p. 1615, doi. 10.1172/JCI59623
- By:
- Publication type:
- Article
Development of HIF-1 inhibitors for cancer therapy.
- Published in:
- Journal of Cellular & Molecular Medicine, 2009, v. 13, n. 9a, p. 2780, doi. 10.1111/j.1582-4934.2009.00876.x
- By:
- Publication type:
- Article
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 2, p. 343, doi. 10.1007/s00280-013-2362-z
- By:
- Publication type:
- Article